HomeAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$38.80
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$38.80
Sarado: Ago 22, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$38.20
Sakop ng araw
$37.75 - $39.69
Sakop ng taon
$23.42 - $62.58
Market cap
2.25B USD
Average na Volume
880.78K
P/E ratio
3.51
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 12.46M | 44.57% |
Gastos sa pagpapatakbo | 45.87M | 29.08% |
Net na kita | -112.02M | -16.54% |
Net profit margin | -899.40 | 19.39% |
Kita sa bawat share | -1.93 | -14.20% |
EBITDA | -125.80M | -20.70% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 938.94M | 64.76% |
Kabuuang asset | 1.47B | 90.31% |
Kabuuang sagutin | 101.68M | -9.66% |
Kabuuang equity | 1.37B | — |
Natitirang share | 58.10M | — |
Presyo para makapag-book | 1.62 | — |
Return on assets | -20.99% | — |
Return on capital | -21.62% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -112.02M | -16.54% |
Cash mula sa mga operasyon | -77.12M | -6.25% |
Cash mula sa pag-invest | 78.97M | 112.02% |
Cash mula sa financing | 65.00K | -94.09% |
Net change in cash | 1.91M | 105.57% |
Malayang cash flow | -51.97M | -32.43% |
Tungkol
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Itinatag
2008
Website
Mga Empleyado
487
